BindingDB PrimarySearch

null

SMILES: COc1cc(Nc2ccc(c(c2)C(F)(F)F)S(=O)(=O)NCC2CC2)cc(OC)c1

InChI Key: InChIKey=PXRZBSVMVTXTQV-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 242431
Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	k_off s^-1	k_on M^-1s^-1	pH	Temp °C
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM242431 (US9422235, 4) Show SMILES Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	19	-10.7	37	n/a	n/a	n/a	n/a	n/a	30
Pharmos Corporation US Patent					Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...				US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2
Pharmos Corporation US Patent					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM242431 (US9422235, 4) Show SMILES Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	29	-10.4	56	n/a	n/a	n/a	n/a	n/a	30
Pharmos Corporation US Patent					Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...				US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2
Pharmos Corporation US Patent					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM242431 (US9422235, 4) Show SMILES Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	29.2	-10.4	58.1	n/a	n/a	n/a	n/a	n/a	30
Pharmos Corporation US Patent					Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...				US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2
Pharmos Corporation US Patent					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM242431 (US9422235, 4) Show SMILES Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	34	-10.4	76	n/a	n/a	n/a	n/a	n/a	30
Pharmos Corporation US Patent					Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...				US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2
Pharmos Corporation US Patent					More data for this Ligand-Target Pair
Cannabinoid receptor 2 (Homo sapiens (Human))	BDBM242431 (US9422235, 4) Show SMILES Show InChI	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	37	-10.3	68	n/a	n/a	n/a	n/a	n/a	30
Pharmos Corporation US Patent					Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...				US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2
Pharmos Corporation US Patent					More data for this Ligand-Target Pair
Cannabinoid receptor 1 (Homo sapiens (Human))	BDBM242431 (US9422235, 4) Show SMILES Show InChI	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	260	-9.13	580	n/a	n/a	n/a	n/a	n/a	30
Pharmos Corporation US Patent					Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...				US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2
Pharmos Corporation US Patent					More data for this Ligand-Target Pair
Cannabinoid receptor 1 (Homo sapiens (Human))	BDBM242431 (US9422235, 4) Show SMILES Show InChI	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	400	-8.87	720	n/a	n/a	n/a	n/a	n/a	30
Pharmos Corporation US Patent					Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...				US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2
Pharmos Corporation US Patent					More data for this Ligand-Target Pair
Cannabinoid receptor 1 (Homo sapiens (Human))	BDBM242431 (US9422235, 4) Show SMILES Show InChI	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.16E+3	-8.23	2.00E+3	n/a	n/a	n/a	n/a	n/a	30
Pharmos Corporation US Patent					Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...				US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2
Pharmos Corporation US Patent					More data for this Ligand-Target Pair
Cannabinoid receptor 1 (Homo sapiens (Human))	BDBM242431 (US9422235, 4) Show SMILES Show InChI	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	1.56E+3	-8.05	3.06E+3	n/a	n/a	n/a	n/a	n/a	30
Pharmos Corporation US Patent					Assay Description The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...				US Patent US9422235 (2016) BindingDB Entry DOI: 10.7270/Q2833QX2
Pharmos Corporation US Patent					More data for this Ligand-Target Pair